Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Healthcare Resilience | Tenet Healthcare demonstrates financial strength with raised EBITDA guidance and improved leverage ratios, showcasing adaptability in a dynamic healthcare landscape |
Volume Dynamics | Explore Tenet's robust inpatient growth projections, driven by an aging population and pandemic aftermath, while navigating temporary outpatient challenges |
Market Positioning | Delve into Tenet's competitive stance against industry leader HCA, with analysts viewing its current trading discount as a potential opportunity for appreciation |
Future Trajectory | Analysts maintain an "Overweight" rating with price targets ranging from $112 to $171, reflecting confidence in Tenet's strategic initiatives and market adaptability |
Metrics to compare | THC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTHCPeersSector | |
---|---|---|---|---|
P/E Ratio | 5.0x | −3.2x | −0.6x | |
PEG Ratio | 0.01 | −0.07 | 0.00 | |
Price/Book | 4.1x | 0.6x | 2.6x | |
Price / LTM Sales | 0.7x | 1.6x | 3.2x | |
Upside (Analyst Target) | 11.8% | 44.4% | 47.5% | |
Fair Value Upside | Unlock | 1.8% | 6.7% | Unlock |